AIM Biotech Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
5
AIM Biotech General Information
Description
Developer of microphysiological systems and organ-on-a-chip platforms designed for drug discovery and biomedical research purposes. The company's platform provides microfluidic tissue culture systems, organoid and biopsy modeling, in vitro human tissue assays, imaging capabilities, contract research services, and custom assay development, enabling pharmaceutical companies and research organizations to study human biology, evaluate drug candidates, and conduct non-animal preclinical research.
Contact Information
Website
www.aimbiotech.comCorporate Office
- 21 Biopolis Road
- Number 01-24 Nucleos
- Singapore, 138567
- Singapore
Corporate Office
- 21 Biopolis Road
- Number 01-24 Nucleos
- Singapore, 138567
- Singapore
AIM Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 03-Oct-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 19-Nov-2020 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Jun-2017 | Completed | Startup |
AIM Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
AIM Biotech Comparisons
Industry
Financing
Details
AIM Biotech Competitors (2)
One of AIM Biotech’s 2 competitors is MIMETAS, a Venture Capital-Backed company based in Oegstgeest, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MIMETAS | Venture Capital-Backed | Oegstgeest, Netherlands | ||||
| Redbud Labs | Venture Capital-Backed | Durham, NC |
AIM Biotech Patents
AIM Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3004596-A1 | Microfluidic platform for investigating cell-based interactions | Active | 11-Nov-2014 | ||
| CA-3004596-C | Microfluidic platform for investigating cell-based interactions | Active | 11-Nov-2014 | ||
| EP-3218300-A1 | Microfluidic platform for investigating cell-based interactions | Active | 11-Nov-2014 | ||
| EP-3218300-A4 | Microfluidic platform for investigating cell-based interactions | Active | 11-Nov-2014 | ||
| EP-3218300-B1 | Microfluidic platform for investigating cell-based interactions | Active | 11-Nov-2014 | C12M23/16 |
AIM Biotech Signals
AIM Biotech Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Elev8.vc | Venture Capital | Minority | ||
| Enterprise Singapore | Government | Minority | ||
| Angel (individual) | Minority | |||
| SEEDS Capital | Corporate Venture Capital | Minority | ||
| Wavemaker Partners | Venture Capital | Minority |
AIM Biotech FAQs
-
When was AIM Biotech founded?
AIM Biotech was founded in 2012.
-
Where is AIM Biotech headquartered?
AIM Biotech is headquartered in Singapore, Singapore.
-
What is the size of AIM Biotech?
AIM Biotech has 10 total employees.
-
What industry is AIM Biotech in?
AIM Biotech’s primary industry is Drug Discovery.
-
Is AIM Biotech a private or public company?
AIM Biotech is a Private company.
-
What is AIM Biotech’s current revenue?
The current revenue for AIM Biotech is .
-
How much funding has AIM Biotech raised over time?
AIM Biotech has raised $4.64M.
-
Who are AIM Biotech’s investors?
Elev8.vc, Enterprise Singapore, , SEEDS Capital, and Wavemaker Partners have invested in AIM Biotech.
-
Who are AIM Biotech’s competitors?
MIMETAS and Redbud Labs are competitors of AIM Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process